{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:08:04Z","timestamp":1777100884220,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972002"],"award-info":[{"award-number":["81972002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s13577-021-00555-7","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T10:02:42Z","timestamp":1621591362000},"page":"1424-1433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3\/9 via the CD64\/AKT\/mTOR pathway"],"prefix":"10.1007","volume":"34","author":[{"given":"Xiaodong","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-9846","authenticated-orcid":false,"given":"Qinchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"7","key":"555_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ijom.2019.01.008","volume":"48","author":"L Hingsammer","year":"2019","unstructured":"Hingsammer L, Seier T, Ikenberg J, Schumann P, Zweifel D, Rucker M, et al. The influence of lymph node ratio on survival and disease recurrence in squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg. 2019;48(7):851\u20136. https:\/\/doi.org\/10.1016\/j.ijom.2019.01.008.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"555_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.oraloncology.2018.10.014","volume":"87","author":"ME Gamez","year":"2018","unstructured":"Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, et al. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral Oncol. 2018;87:43\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.10.014.","journal-title":"Oral Oncol"},{"issue":"2","key":"555_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/0008-5472.CAN-07-3063","volume":"68","author":"K Yamauchi","year":"2008","unstructured":"Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H, et al. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res. 2008;68(2):516\u201320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3063.","journal-title":"Cancer Res"},{"issue":"8","key":"555_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cancers10080251","volume":"10","author":"SS Savant","year":"2018","unstructured":"Savant SS, Sriramkumar S, O\u2019Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial Ovarian cancer. Cancers (Basel). 2018;10(8):251. https:\/\/doi.org\/10.3390\/cancers10080251.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"555_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2010.02.019","volume":"295","author":"Y Wang","year":"2010","unstructured":"Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, et al. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett. 2010;295(1):110\u201323. https:\/\/doi.org\/10.1016\/j.canlet.2010.02.019.","journal-title":"Cancer Lett"},{"key":"555_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","volume":"454","author":"J Zhai","year":"2019","unstructured":"Zhai J, Shen J, Xie G, Wu J, He M, Gao L, et al. Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 2019;454:37\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2019.04.002.","journal-title":"Cancer Lett"},{"issue":"3","key":"555_CR7","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.4049\/jimmunol.164.3.1514","volume":"164","author":"MP Stein","year":"2000","unstructured":"Stein MP, Mold C, Du Clos TW. C-reactive protein binding to murine leukocytes requires Fc gamma receptors. J Immunol. 2000;164(3):1514\u201320. https:\/\/doi.org\/10.4049\/jimmunol.164.3.1514.","journal-title":"J Immunol"},{"issue":"1","key":"555_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13287-016-0377-1","volume":"7","author":"J Chen","year":"2016","unstructured":"Chen J, Gu Z, Wu M, Yang Y, Zhang J, Ou J, et al. C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1alpha via CD64\/PI3k\/Akt and MAPK\/ERK signalling pathways. Stem Cell Res Ther. 2016;7(1):114. https:\/\/doi.org\/10.1186\/s13287-016-0377-1.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"555_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/01.ATV.0000104014.24367.16","volume":"24","author":"TN Williams","year":"2004","unstructured":"Williams TN, Zhang CX, Game BA, He L, Huang Y. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler Thromb Vasc Biol. 2004;24(1):61\u20136. https:\/\/doi.org\/10.1161\/01.ATV.0000104014.24367.16.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"43","key":"555_CR10","doi-asserted-by":"publisher","first-page":"40775","DOI":"10.1074\/jbc.M205378200","volume":"277","author":"T Khreiss","year":"2002","unstructured":"Khreiss T, J\u00f3zsef L, Hossain S, Chan JS, Potempa LA, Filep JG. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem. 2002;277(43):40775\u201381. https:\/\/doi.org\/10.1074\/jbc.M205378200.","journal-title":"J Biol Chem"},{"issue":"12","key":"555_CR11","doi-asserted-by":"publisher","first-page":"e0143080","DOI":"10.1371\/journal.pone.0143080","volume":"10","author":"S Shrotriya","year":"2015","unstructured":"Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive protein is an important biomarker for prognosis tumour recurrence and treatment response in adult solid tumours: a systematic review. PLoS ONE. 2015;10(12):e0143080. https:\/\/doi.org\/10.1371\/journal.pone.0143080.","journal-title":"PLoS ONE"},{"issue":"6","key":"555_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.pan.2015.09.016","volume":"15","author":"T Kishi","year":"2015","unstructured":"Kishi T, Nakamura A, Itasaka S, Shibuya K, Matsumoto S, Kanai M, et al. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Pancreatology. 2015;15(6):694\u2013700. https:\/\/doi.org\/10.1016\/j.pan.2015.09.016.","journal-title":"Pancreatology"},{"issue":"1","key":"555_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.lungcan.2008.04.011","volume":"63","author":"JG Lee","year":"2009","unstructured":"Lee JG, Cho BC, Bae MK, Lee CY, Park IK, Kim DJ, et al. Preoperative C-reactive protein levels are associated with tumour size and lymphovascular invasion in resected non-small cell lung cancer. Lung Cancer. 2009;63(1):106\u201310. https:\/\/doi.org\/10.1016\/j.lungcan.2008.04.011.","journal-title":"Lung Cancer"},{"issue":"1","key":"555_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/onc.2017.298","volume":"37","author":"ES Kim","year":"2018","unstructured":"Kim ES, Kim SY, Koh M, Lee HM, Kim K, Jung J, et al. C-reactive protein binds to integrin alpha2 and Fcgamma receptor I, leading to breast cell adhesion and breast cancer progression. Oncogene. 2018;37(1):28\u201338. https:\/\/doi.org\/10.1038\/onc.2017.298.","journal-title":"Oncogene"},{"issue":"3","key":"555_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ccr.2007.08.008","volume":"12","author":"J Yang","year":"2007","unstructured":"Yang J, Wezeman M, Zhang X, Lin P, Wang M, Qian J, et al. Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumour cells from apoptosis. Cancer Cell. 2007;12(3):252\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2007.08.008.","journal-title":"Cancer Cell"},{"issue":"3","key":"555_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/abbs\/gmy004","volume":"50","author":"J Du","year":"2018","unstructured":"Du J, Hu W, Yang C, Wang Y, Wang X, Yang P. C-reactive protein is associated with the development of tongue squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai). 2018;50(3):238\u201345. https:\/\/doi.org\/10.1093\/abbs\/gmy004.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"5","key":"555_CR17","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","volume":"93","author":"JS Damiano","year":"1999","unstructured":"Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999;93(5):1658\u201367.","journal-title":"Blood"},{"issue":"9","key":"555_CR18","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-07-2223","volume":"14","author":"MB Meads","year":"2008","unstructured":"Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumour sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14(9):2519\u201326. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-2223.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"555_CR19","first-page":"471","volume":"32","author":"CS Wang","year":"2009","unstructured":"Wang CS, Sun CF. C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J. 2009;32(5):471\u201382.","journal-title":"Chang Gung Med J"},{"key":"555_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.immunol.21.120601.141011","volume":"21","author":"RC Monteiro","year":"2003","unstructured":"Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol. 2003;21:177\u2013204. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141011.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"555_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2005.06.022","volume":"100","author":"RE Schmidt","year":"2005","unstructured":"Schmidt RE, Gessner JE. Fc receptors and their interaction with complement in autoimmunity. Immunol Lett. 2005;100(1):56\u201367. https:\/\/doi.org\/10.1016\/j.imlet.2005.06.022.","journal-title":"Immunol Lett"},{"issue":"11","key":"555_CR22","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.drudis.2019.09.001","volume":"24","author":"MA Khan","year":"2019","unstructured":"Khan MA, Jain VK, Rizwanullah M, Ahmad J, Jain K. PI3K\/AKT\/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges. Drug Discov Today. 2019;24(11):2181\u201391. https:\/\/doi.org\/10.1016\/j.drudis.2019.09.001.","journal-title":"Drug Discov Today"},{"issue":"41","key":"555_CR23","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.18632\/oncotarget.27064","volume":"10","author":"XS Yu","year":"2019","unstructured":"Yu XS, Du J, Fan YJ, Liu FJ, Cao LL, Liang N, et al. Retraction: activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K\/AKT\/mTOR signalling pathway. Oncotarget. 2019;10(41):4252. https:\/\/doi.org\/10.18632\/oncotarget.27064.","journal-title":"Oncotarget"},{"issue":"1","key":"555_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/1878-0261.12728","volume":"15","author":"Q Wu","year":"2021","unstructured":"Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K\/AKT\/mTOR pathway. Mol Oncol. 2021;15(1):299\u2013316. https:\/\/doi.org\/10.1002\/1878-0261.12728.","journal-title":"Mol Oncol"},{"issue":"4","key":"555_CR25","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3892\/or.2019.6991","volume":"41","author":"Y Yang","year":"2019","unstructured":"Yang Y, Dai W, Sun Y, Zhao Z. Long non-coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K\/Akt\/mTOR pathway in acute myeloid leukaemia cells. Oncol Rep. 2019;41(4):2311\u201320. https:\/\/doi.org\/10.3892\/or.2019.6991.","journal-title":"Oncol Rep"},{"key":"555_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fonc.2019.00422","volume":"9","author":"J Wu","year":"2019","unstructured":"Wu J, Cheng Z, Xu X, Fu J, Wang K, Liu T, et al. Aurora-A induces chemoresistance through activation of the AKT\/mTOR pathway in endometrial cancer. Front Oncol. 2019;9:422. https:\/\/doi.org\/10.3389\/fonc.2019.00422.","journal-title":"Front Oncol"},{"issue":"6","key":"555_CR27","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3892\/mmr.2014.2584","volume":"10","author":"DL Liu","year":"2014","unstructured":"Liu DL, Bu HQ, Jin HM, Zhao JF, Li Y, Huang H. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial Caspase-dependent signalling pathway. Mol Med Rep. 2014;10(6):3027\u201334. https:\/\/doi.org\/10.3892\/mmr.2014.2584.","journal-title":"Mol Med Rep"},{"issue":"3","key":"555_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1083\/jcb.151.3.483","volume":"151","author":"H Zhou","year":"2000","unstructured":"Zhou H, Li XM, Meinkoth J, Pittman RN. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol. 2000;151(3):483\u201394. https:\/\/doi.org\/10.1083\/jcb.151.3.483.","journal-title":"J Cell Biol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-021-00555-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T09:30:14Z","timestamp":1628069414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-021-00555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1007\/s13577-021-00555-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"14 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical consent was granted from the Ethics Committee of Zibo Central Hospital for studies involving patients. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. Ethical approval of the animal study was granted by the Animal Ethics Committee of Zibo Central Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}